GALWAY, Ireland , June 23, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that its Board of Directors appointed Dr. Joon Lee, CEO at Emory Healthcare, Inc., to the Board as an independent director, effective June 18, 2025. Dr. Lee will serve on the Science and Technology Committee and Compensation and Talent Committee of the Board.
Medtronic (MDT) reported earnings 30 days ago. What's next for the stock?
Medtronic remains a dependable dividend aristocrat, but its long-term total shareholder returns lag significantly behind peers like Johnson & Johnson and Stryker. Despite a solid 2025 performance, the stock's recent gains stem from a low base, and it still trades well below its 2021 highs. Earnings growth is steady but uninspiring, with margin pressure and tariff risks highlighting operational challenges versus higher-quality competitors.
![]() 0Y6X 2 months ago | Other | $0.7 Per Share |
![]() 0Y6X 6 months ago | Other | $0.7 Per Share |
![]() 0Y6X 8 months ago | Other | $0.7 Per Share |
![]() 0Y6X 11 months ago | Other | $0.7 Per Share |
![]() 0Y6X 21 Mar 2024 | Other | $0.69 Per Share |
19 Aug 2025 (In 1 month) Date | | - Cons. EPS | - EPS |
22 May 2025 Date | | - Cons. EPS | - EPS |
21 May 2025 Date | | - Cons. EPS | 0.82 EPS |
18 Feb 2025 Date | | - Cons. EPS | 1.01 EPS |
19 Nov 2024 Date | | - Cons. EPS | 0.99 EPS |
![]() 0Y6X 2 months ago | Other | $0.7 Per Share |
![]() 0Y6X 6 months ago | Other | $0.7 Per Share |
![]() 0Y6X 8 months ago | Other | $0.7 Per Share |
![]() 0Y6X 11 months ago | Other | $0.7 Per Share |
![]() 0Y6X 21 Mar 2024 | Other | $0.69 Per Share |
19 Aug 2025 (In 1 month) Date | | - Cons. EPS | - EPS |
22 May 2025 Date | | - Cons. EPS | - EPS |
21 May 2025 Date | | - Cons. EPS | 0.82 EPS |
18 Feb 2025 Date | | - Cons. EPS | 1.01 EPS |
19 Nov 2024 Date | | - Cons. EPS | 0.99 EPS |
Medical - Devices Industry | Healthcare Sector | Mr. Geoffrey Straub Martha CEO | LSE Exchange | IE00BTN1Y115 ISIN |
IE Country | 95,000 Employees | 27 Jun 2025 Last Dividend | 27 Sep 1999 Last Split | 13 Jan 1978 IPO Date |
Medtronic plc is a global leader in medical technology, specializing in the development, manufacture, and sale of device-based medical therapies. Serving healthcare systems, physicians, clinicians, and patients around the world, the company is dedicated to alleviating pain, restoring health, and extending life for millions of people. Founded in 1949 and headquartered in Dublin, Ireland, Medtronic operates across various medical domains through its diverse portfolio which includes cardiovascular, medical surgical, neuroscience, and diabetes treatments and technologies.
Medtronic’s comprehensive range of products and services is categorized into four primary segments: